Skip to main content
. 2020 Apr 22;44(3):275–281. doi: 10.1016/j.clinre.2020.04.001

Hepatitis B Treatments.

anti-HBV antiviral/COVID-19 treatment Remdesivir Lopinavir/Ritonavir Hydroxychloroquine
Tenofovir disoproxil Weak interaction risk Moderate interaction risk–Increase concentrations of tenofovir – Renal function monitoring Weak interaction risk
Entecavir Weak interaction risk Weak interaction risk Weak interaction risk